166 related articles for article (PubMed ID: 12849789)
1. Vaccines for the prevention of neglected diseases--dengue fever.
Pang T
Curr Opin Biotechnol; 2003 Jun; 14(3):332-6. PubMed ID: 12849789
[TBL] [Abstract][Full Text] [Related]
2. Vaccines licensed and in clinical trials for the prevention of dengue.
Torresi J; Ebert G; Pellegrini M
Hum Vaccin Immunother; 2017 May; 13(5):1059-1072. PubMed ID: 28281864
[TBL] [Abstract][Full Text] [Related]
3. Vaccines and immunization strategies for dengue prevention.
Liu Y; Liu J; Cheng G
Emerg Microbes Infect; 2016 Jul; 5(7):e77. PubMed ID: 27436365
[TBL] [Abstract][Full Text] [Related]
4. New vaccines for neglected parasitic diseases and dengue.
Beaumier CM; Gillespie PM; Hotez PJ; Bottazzi ME
Transl Res; 2013 Sep; 162(3):144-55. PubMed ID: 23578479
[TBL] [Abstract][Full Text] [Related]
5. [Dengue fever: from disease to vaccination].
Teyssou R
Med Trop (Mars); 2009 Aug; 69(4):333-4. PubMed ID: 19725380
[TBL] [Abstract][Full Text] [Related]
6. Impact of dengue virus infection and its control.
Igarashi A
FEMS Immunol Med Microbiol; 1997 Aug; 18(4):291-300. PubMed ID: 9348165
[TBL] [Abstract][Full Text] [Related]
7. Vaccination and antiviral treatment of neglected diseases caused by flaviviral infections.
Schleich K; Nürnberger C; Sobanski A; Efferth T
Curr Med Chem; 2011; 18(4):604-14. PubMed ID: 21143108
[TBL] [Abstract][Full Text] [Related]
8. Review of dengue virus and the development of a vaccine.
Murrell S; Wu SC; Butler M
Biotechnol Adv; 2011; 29(2):239-47. PubMed ID: 21146601
[TBL] [Abstract][Full Text] [Related]
9. Dengue in Southeast Asia: epidemiological characteristics and strategic challenges in disease prevention.
Ooi EE; Gubler DJ
Cad Saude Publica; 2009; 25 Suppl 1():S115-24. PubMed ID: 19287856
[TBL] [Abstract][Full Text] [Related]
10. Challenges in reducing dengue burden; diagnostics, control measures and vaccines.
Lam SK
Expert Rev Vaccines; 2013 Sep; 12(9):995-1010. PubMed ID: 24053394
[TBL] [Abstract][Full Text] [Related]
11. DENGUE VACCINES.
Thisyakorn U; Thisyakorn C
Southeast Asian J Trop Med Public Health; 2015; 46 Suppl 1():138-45. PubMed ID: 26506740
[TBL] [Abstract][Full Text] [Related]
12. Dengue and yellow fever--challenges for the development and use of vaccines.
Monath TP
N Engl J Med; 2007 Nov; 357(22):2222-5. PubMed ID: 18046026
[No Abstract] [Full Text] [Related]
13. Dengue vaccine development: strategies and challenges.
Ramakrishnan L; Pillai MR; Nair RR
Viral Immunol; 2015 Mar; 28(2):76-84. PubMed ID: 25494228
[TBL] [Abstract][Full Text] [Related]
14. Dengue vaccines approach the finish line.
Edelman R
Clin Infect Dis; 2007 Jul; 45 Suppl 1():S56-60. PubMed ID: 17582571
[TBL] [Abstract][Full Text] [Related]
15. Editorial: the challenge of dengue vaccine development and introduction.
Deen JL
Trop Med Int Health; 2004 Jan; 9(1):1-3. PubMed ID: 14728601
[No Abstract] [Full Text] [Related]
16. Dengue virus vaccine development.
Yauch LE; Shresta S
Adv Virus Res; 2014; 88():315-72. PubMed ID: 24373316
[TBL] [Abstract][Full Text] [Related]
17. [Dengue and dengue hemorrhagic fever: research priorities].
Guzmán MG; García G; Kourí G
Rev Panam Salud Publica; 2006 Mar; 19(3):204-15. PubMed ID: 16640849
[TBL] [Abstract][Full Text] [Related]
18. Severe dengue: the need for new case definitions.
Rigau-Pérez JG
Lancet Infect Dis; 2006 May; 6(5):297-302. PubMed ID: 16631550
[TBL] [Abstract][Full Text] [Related]
19. Development of a recombinant, chimeric tetravalent dengue vaccine candidate.
Osorio JE; Partidos CD; Wallace D; Stinchcomb DT
Vaccine; 2015 Dec; 33(50):7112-20. PubMed ID: 26585500
[TBL] [Abstract][Full Text] [Related]
20. Dengue vaccine.
Simasathien S; Watanaveeradej V
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S363-77. PubMed ID: 16858980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
